In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Ventyx Biosciences Inc (NASDAQ: VTYX) closed at $4.47 up 2.76% from its previous closing price of $4.35. In other words, the price has increased by $2.76 from its previous closing price. On the day, 0.91 million shares were traded. VTYX stock price reached its highest trading level at $4.63 during the session, while it also had its lowest trading level at $4.26.
Ratios:
For a deeper understanding of Ventyx Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.87 and its Current Ratio is at 11.87. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on March 12, 2024, Upgraded its rating to Overweight and sets its target price to $16 from $7 previously.
On March 12, 2024, Oppenheimer Upgraded its rating to Outperform which previously was Perform but kept the price unchanged to $12.
Wells Fargo Downgraded its Overweight to Equal Weight on November 07, 2023, whereas the target price for the stock was revised from $77 to $8.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 02 ’24 when Mohan Raju sold 4,312 shares for $5.40 per share. The transaction valued at 23,299 led to the insider holds 1,578,250 shares of the business.
Krueger Christopher W sold 1,651 shares of VTYX for $8,921 on Apr 02 ’24. The CHIEF BUSINESS OFFICER now owns 284,999 shares after completing the transaction at $5.40 per share. On Apr 02 ’24, another insider, Nuss John, who serves as the CHIEF SCIENTIFIC OFFICER of the company, sold 1,651 shares for $5.40 each. As a result, the insider received 8,921 and left with 264,998 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTYX now has a Market Capitalization of 315131424 and an Enterprise Value of 25084836.
Stock Price History:
Over the past 52 weeks, VTYX has reached a high of $40.58, while it has fallen to a 52-week low of $1.87. The 50-Day Moving Average of the stock is -23.10%, while the 200-Day Moving Average is calculated to be -71.00%.
Shares Statistics:
For the past three months, VTYX has traded an average of 3.99M shares per day and 990080 over the past ten days. A total of 59.24M shares are outstanding, with a floating share count of 47.78M. Insiders hold about 19.36% of the company’s shares, while institutions hold 89.18% stake in the company. Shares short for VTYX as of 1711584000 were 9219868 with a Short Ratio of 2.31, compared to 1709164800 on 9192392. Therefore, it implies a Short% of Shares Outstanding of 9219868 and a Short% of Float of 18.21.
Earnings Estimates
The stock of Ventyx Biosciences Inc (VTYX) is currently being evaluated by Treasury Yield 30 Years analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is $11.94, with high estimates of $4.47 and low estimates of $7.58.
